Written by The HG Collective · Reviewed by HG Clinicians Expert Panel · Last reviewed: July 2026
Treating pregnancy sickness and HG
Most people with mild, usual pregnancy sickness can manage their symptoms themselves and will not need medication. For others, symptoms do not settle, begin to interfere with daily life or make eating and drinking difficult. In that situation, anti-sickness medication may help. Hyperemesis gravidarum (HG) is at the severe end of pregnancy sickness and usually needs active medical treatment.
Care should be based on how severe your symptoms are, whether you can eat and drink, how symptoms affect daily life and how you respond to treatment. You do not need to wait until you are dehydrated, losing weight or meet the definition of HG before asking a healthcare professional for help.
If you do need treatment, there is no single option that works for everyone. The plan may need to be adjusted, particularly with HG. You may need more than one anti-sickness medicine, a different way of taking it, intravenous fluids or hospital-based care. Needing further treatment does not mean you have failed—it means the plan needs to change.
Food, fluids and practical measures
For mild pregnancy sickness, practical measures may be all that is needed. If symptoms persist, interfere with normal activities or make it difficult to eat or drink, these measures should support appropriate treatment—not replace it or delay medical care.
If you can eat or drink, it may help to:
- have small amounts regularly rather than trying to manage a full meal or large drink;
- choose whatever food and fluid you can tolerate—this may change from one day to the next;
- try cold foods or drinks if cooking smells make symptoms worse;
- keep tolerated snacks and drinks within easy reach;
- separate food and fluids if taking them together is difficult;
- rest when you can and reduce exposure to personal triggers, such as strong smells, heat, movement, light or noise; and
- accept practical help with cooking, childcare, work and household tasks.
Some people find plain or carbohydrate-based foods easier, but there is no single “HG diet”. The immediate priority is getting in what you can. You should not be made to feel guilty if your diet is limited while you are unwell.
Some people try P6 acupressure wristbands. A small trial reported improvement when acupressure was used alongside standard inpatient treatment, but the evidence is limited. Acupressure should only be used as an addition to appropriate treatment.
Ginger is sometimes suggested for ordinary pregnancy sickness, but evidence from ordinary nausea and vomiting in pregnancy should not be assumed to apply to HG. RCOG advises healthcare professionals not to suggest ginger for HG. Many people with HG have already tried it, and a survey of people previously hospitalised with HG found it was usually ineffective and could cause unpleasant effects or worsen symptoms.
RCOG's patient information says most people with nausea and vomiting of pregnancy can manage their symptoms themselves. It advises seeking help from a GP if symptoms do not settle or stop someone carrying out daily activities; anti-sickness medication can then be prescribed.[5] RCOG's clinical guideline includes oral hydration, dietary advice, rest and time away from work where needed as part of community care. These measures may be sufficient for mild symptoms, but sit alongside medication or escalation of care when those are required.[1]
One double-blind randomised controlled trial studied P6 acupressure as an adjunct to standard inpatient treatment in low-risk, spontaneously conceived singleton pregnancies affected by severe nausea and vomiting. It reported improved symptom scores and shorter hospital stays in the acupressure group. This was a single study in a selected population and does not establish acupressure as a replacement for medical treatment.[2]
The study underlying RCOG's ginger statement was a self-selected, cross-sectional online survey—not a cohort study or randomised trial. The paper contains a small reporting inconsistency: its abstract describes 512 respondents hospitalised for HG within the previous five years, while the results section reports 514 eligible respondents, all pregnant within the previous ten years, of whom 457 had been pregnant within five years. For that reason, this page does not present the sample size as unambiguous.[3]
The full results report that 439 of 501 respondents had tried ginger; 376 of the 429 who rated its helpfulness said it was not helpful at all. Negative effects were reported by 225 respondents, and 305 of 384 respondents who answered the trust question gave a score indicating reduced trust in the healthcare professional who suggested ginger.[3] These are self-reported survey findings with varying denominators, not estimates of how everyone with HG will respond. RCOG cites the survey and advises healthcare professionals not to suggest ginger for HG because it may cause unpleasant effects and delay access to effective treatment.[1]
Dietetic guidance from Cambridge University Hospitals emphasises eating and drinking whatever can be tolerated, using small amounts frequently, and not worrying about achieving an ideal diet while acutely unwell. Nutritional supplements and dietetic input may be useful when intake remains inadequate.[4]
References
- [1] Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum: Green-top Guideline No. 69. BJOG. 2024;131(7):e1–e30. https://doi.org/10.1111/1471-0528.17739
- [2] Adlan A-S, Chooi KY, Mat Adenan NA. Acupressure as adjuvant treatment for the inpatient management of nausea and vomiting in early pregnancy: a double-blind randomized controlled trial. Journal of Obstetrics and Gynaecology Research. 2017;43(4):662–668. https://doi.org/10.1111/jog.13269
- [3] Dean CR, O'Hara ME. Ginger is ineffective for hyperemesis gravidarum, and causes harm: an internet-based survey of sufferers. MIDIRS Midwifery Digest. 2015;25(4):449–455. No DOI was assigned. Full-text copy
- [4] Cambridge University Hospitals NHS Foundation Trust. Dietary advice for hyperemesis gravidarum. https://www.cuh.nhs.uk/patient-information/dietary-advice-for-hyperemesis-gravidarum/
- [5] Royal College of Obstetricians and Gynaecologists. Pregnancy sickness (nausea and vomiting of pregnancy and hyperemesis gravidarum). https://www.rcog.org.uk/for-the-public/browse-our-patient-information/pregnancy-sickness-nausea-and-vomiting-of-pregnancy-and-hyperemesis-gravidarum/
Anti-sickness medication—a step-by-step approach
Not everyone with pregnancy sickness needs medication. If mild symptoms are manageable and you can eat, drink and continue your usual activities, self-care may be enough. If symptoms do not settle, affect daily life or make eating and drinking difficult, anti-sickness medication can be used in pregnancy, including during the first trimester. You do not need to wait until you are dehydrated or losing weight before asking for help.
RCOG recommends a stepwise approach:
- First-line options include doxylamine/pyridoxine (Xonvea®), antihistamines such as cyclizine or promethazine, and phenothiazines such as prochlorperazine or chlorpromazine.
- Second-line options include ondansetron, metoclopramide and domperidone. These may be used when first-line medicines have not worked well enough or have caused unacceptable side effects for the pregnant person.
- Third-line treatment means corticosteroids. These are reserved for severe cases that have not responded to intravenous fluids and regular anti-sickness medicines.
“First-line” and “second-line” do not mean that one medicine will work better for everyone. The order is based largely on the available pregnancy-safety evidence and recognised side effects for the pregnant person. If one medicine is not enough, RCOG recommends combining medicines from different drug classes rather than simply continuing with ineffective treatment.
If you cannot keep tablets down, ask about another route. Depending on the medicine and local service, treatment may be available as a buccal or rectal preparation, or by injection, infusion or another non-oral route. The correct route matters: a medicine cannot help if it is repeatedly vomited back up.
Do not change the dose, combine medicines or stop corticosteroids without medical advice. If you develop an unusual reaction—such as muscle spasms, abnormal movements, severe restlessness or marked stiffness—seek medical advice promptly.
RCOG gives a Grade A recommendation for initial treatment with anti-H1 antihistamines, phenothiazines or doxylamine/pyridoxine. Its treatment appendix lists doxylamine/pyridoxine, cyclizine, prochlorperazine, promethazine and chlorpromazine as first-line options. Metoclopramide, domperidone and ondansetron are listed as second-line options, with corticosteroids as third-line therapy.[1]
The stepwise order is based predominantly on safety data because there is no clear evidence that one anti-sickness drug class is consistently more effective than the others. RCOG recommends combining drugs from different classes when one medicine is insufficient and considering non-oral routes when oral medication is not tolerated or absorbed.[1]
RCOG describes ondansetron as safe and effective and says its second-line use should not be discouraged when first-line medicines are ineffective. The guideline acknowledges a possible very small increase in the absolute risk of orofacial clefting with first-trimester exposure; this should be balanced against the risks of poorly managed HG. UKTIS/BUMPS similarly describes any possible increase as very small and notes that most exposed pregnancies are not affected.[1] [2]
Metoclopramide is considered safe and effective but remains second line because it can cause extrapyramidal reactions—movement-related side effects such as dystonia. RCOG advises asking about previous reactions and stopping the medicine promptly if an adverse reaction occurs. Its guidance also contains specific precautions for intravenous administration.[1]
Corticosteroids should be used only after conventional treatment with intravenous fluids and regular anti-sickness medicines has been ineffective. When they are needed for longer treatment, the dose is reduced gradually to the lowest amount that controls symptoms; blood pressure and diabetes screening also require attention.[1]
A 2025 correction to the guideline states that prochlorperazine should not be administered intravenously. This page therefore does not assign individual routes to particular medicines; the prescriber must select an appropriate preparation and route.[3]
References
- [1] Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum: Green-top Guideline No. 69. BJOG. 2024;131(7):e1–e30. https://doi.org/10.1111/1471-0528.17739
- [2] UK Teratology Information Service. Ondansetron. Best Use of Medicines in Pregnancy. Version 5.0, January 2025. https://www.medicinesinpregnancy.org/leaflets-a-z/ondansetron/
- [3] Correction to “The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)”. BJOG. 2025;132(10):1541. https://doi.org/10.1111/1471-0528.18258
Understanding medication safety
It is completely understandable to worry about taking medication during pregnancy. Two different questions are often grouped together, so it can help to separate them:
- Side effects are unwanted effects the pregnant person may experience while taking a medicine, such as drowsiness, constipation, restlessness or movement-related reactions. The possible side effects differ between medicines.
- Pregnancy safety means the evidence about whether a medicine may affect the pregnancy or developing baby. This is a separate question and must be considered medicine by medicine.
The decision is not between taking a medicine and having a risk-free pregnancy. When symptoms are severe, poorly controlled HG also carries risks, including dehydration, malnutrition, electrolyte disturbance, blood clots and serious effects on physical and mental health.
Many of the anti-sickness medicines recommended by RCOG have extensive and reassuring pregnancy safety data. Medicines can still cause side effects for the pregnant person even when the evidence about the baby is reassuring. The balance of benefits and risks is not identical for every person or every medicine. Your clinician or pharmacist should explain why a medicine is being offered, the common side effects you might experience, the specific evidence about use in pregnancy and what to do if it does not work.
If you are worried about a prescription, ask for an individual risk–benefit discussion rather than stopping it without advice. You may also find the independent patient information from Best Use of Medicines in Pregnancy (BUMPS) helpful.
RCOG's evidence review found no increase in overall teratogenic risk or other adverse pregnancy outcomes for several established anti-sickness medicines, including commonly used antihistamines, phenothiazines and dopamine antagonists. It recommends that these medicines can and should be used with confidence in primary and secondary care when clinically needed.[1]
Side effects for the pregnant person and pregnancy safety for the baby are different evidence questions. The pregnancy-safety discussion is also medicine-specific. For example, promethazine has reassuring pregnancy data,[2] while ondansetron carries a possible very small first-trimester orofacial-cleft signal that must be weighed against its potential benefit and the harms of uncontrolled disease.[3] This is why broad statements that every medicine is completely risk-free—or that medication should always be avoided—are both misleading.
BUMPS patient leaflets are based on scientific assessments produced by the UK Teratology Information Service and are designed to support informed decisions between patients and healthcare professionals.[4]
References
- [1] Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum: Green-top Guideline No. 69. BJOG. 2024;131(7):e1–e30. https://doi.org/10.1111/1471-0528.17739
- [2] UK Teratology Information Service. Promethazine. Best Use of Medicines in Pregnancy. Version 4.0, June 2025. https://www.medicinesinpregnancy.org/leaflets-a-z/promethazine/
- [3] UK Teratology Information Service. Ondansetron. Best Use of Medicines in Pregnancy. Version 5.0, January 2025. https://www.medicinesinpregnancy.org/leaflets-a-z/ondansetron/
- [4] UK Teratology Information Service. Best Use of Medicines in Pregnancy. https://www.medicinesinpregnancy.org/
Fluids, vitamins and hospital-based treatment
If you cannot drink enough, keep medication down or manage safely at home, you may need ambulatory day care or admission to hospital. Treatment can include:
- fluids through a drip;
- anti-sickness medication by a route you can absorb;
- blood tests and correction of electrolyte disturbances;
- vitamin B1 (thiamine);
- assessment and treatment of complications; and
- blood-thinning injections when indicated to reduce the risk of a blood clot.
Why thiamine matters
Thiamine stores can become depleted when food intake has been severely reduced or vomiting has continued. Severe deficiency can cause Wernicke's encephalopathy, a rare but serious and preventable neurological condition.
RCOG says thiamine should be given to everyone admitted with vomiting or severely reduced dietary intake, especially before dextrose (glucose) or parenteral nutrition. Dextrose is not recommended as routine replacement fluid for NVP or HG because it can trigger or worsen Wernicke's encephalopathy in someone who is thiamine deficient.
This is a clinical safety responsibility for the treating team. You should not have to manage the order of intravenous treatment yourself.
Fluids and blood-clot prevention
For intravenous rehydration, RCOG recommends sodium chloride 0.9% with potassium added as needed, guided by daily electrolyte monitoring. The exact fluid, amount and rate must be prescribed for the individual.
People admitted with HG should be offered an assessment and, where appropriate, low-molecular-weight heparin injections to prevent venous thromboembolism. People treated in the community should also have their individual blood-clot risk considered.
RCOG identifies intravenous fluid and electrolyte replacement as a central part of ambulatory and inpatient care. It recommends sodium chloride 0.9% with additional potassium chloride, guided by daily electrolyte monitoring. A 2025 correction replaced the informal term “normal saline” with “sodium chloride 0.9%”, and a 2026 correction amended one infusion time in the ambulatory-care algorithm. This page deliberately does not provide infusion rates, which must be prescribed clinically.[1] [2] [3]
RCOG recommends thiamine—oral or intravenous as clinically appropriate—for everyone admitted with vomiting or severely reduced dietary intake, particularly before dextrose or parenteral nutrition. It advises against dextrose as routine replacement fluid because glucose-containing solutions can precipitate Wernicke's encephalopathy in thiamine-deficient states.[1]
A systematic review identified 177 published cases of Wernicke's encephalopathy associated with HG. The review found that thiamine treatment was frequently absent or inadequate and that intravenous glucose was reported to have exacerbated the condition in some cases. Because case reports cannot establish the incidence of the complication, this page describes it as rare rather than giving an unsupported percentage estimate.[4]
RCOG recommends that people admitted with HG are offered thromboprophylaxis with low-molecular-weight heparin and that those treated in the community have their venous-thromboembolism risk assessed.[1]
References
- [1] Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum: Green-top Guideline No. 69. BJOG. 2024;131(7):e1–e30. https://doi.org/10.1111/1471-0528.17739
- [2] Correction to “The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)”. BJOG. 2025;132(10):1541. https://doi.org/10.1111/1471-0528.18258
- [3] Correction to “The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)”. BJOG. 2026;133(9):1823. https://doi.org/10.1111/1471-0528.70298
- [4] Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019;236:84–93. https://doi.org/10.1016/j.ejogrb.2019.03.006
If symptoms continue despite treatment
If treatment is not controlling your symptoms, the answer should be a review and escalation of care—not simply being told to persevere. Your team may need to:
- check that medication is being absorbed and taken at effective intervals;
- change the route or combine medicines from different classes;
- treat reflux, gastritis or constipation that is making symptoms worse;
- arrange dietetic advice or oral nutritional supplements;
- assess your physical health, mental health and social circumstances;
- involve obstetric medicine, gastroenterology, pharmacy, dietetics or other specialists; or
- consider enteral tube feeding or parenteral nutrition in severe, refractory cases after other medical treatments have failed.
Tube feeding and parenteral nutrition are specialist treatments with important risks. They are not routine early treatment, but they should remain available as part of multidisciplinary care when symptoms and nutritional intake cannot be managed by other measures.
If your symptoms worsen again after initial improvement, contact your healthcare team. HG treatment often needs ongoing prescriptions, follow-up and adjustment rather than a single episode of care.
RCOG recommends combining anti-sickness medicines from different classes when a single medicine is ineffective and using an alternative route when persistent vomiting prevents oral absorption. Histamine H2-receptor blockers or proton-pump inhibitors may be used for gastro-oesophageal reflux, oesophagitis or gastritis. Oral nutritional supplements and dietetic support may help when food intake is inadequate or very restricted.[1]
The guideline recommends assessment of both physical and mental health and referral for psychological support when needed. It is explicit that psychological ill health may result from the severity and prolonged burden of HG; it is not presented as the cause of the condition.[1]
A 2026 mixed-methods systematic review of 64 international studies found that depression and anxiety were generally higher among people with HG than controls and that greater HG or NVP symptom severity was associated with greater psychological burden. Its qualitative synthesis identified psychological burden and trauma, invalidation and unmet care needs, disruption to daily life, identity and relationships, and support and coping. Women valued specialist services and psychological support. The integrated findings indicated that psychological morbidity was associated with both symptom severity and experiences of care, supporting care that addresses emotional wellbeing alongside effective physical treatment.[2]
When all other medical therapies have failed to control symptoms sufficiently, RCOG says enteral tube feeding or parenteral nutrition should be considered alongside ongoing treatment, with gastroenterology involvement and a multidisciplinary team. Parenteral nutrition is a high-risk intervention associated with complications including infection, thrombosis and metabolic disturbance, so it should not be used routinely or without specialist monitoring.[1]
References
- [1] Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum: Green-top Guideline No. 69. BJOG. 2024;131(7):e1–e30. https://doi.org/10.1111/1471-0528.17739
- [2] Mills A, Glaister P, Heys S, Hibberd C, Coxon K. Experiences of Psychological Burden and Care in Women with Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Mixed-Methods Systematic Review. Midwifery. 2026;104956. https://doi.org/10.1016/j.midw.2026.104956